UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of February, 2004
BSN Glasspack S.A.
(Translation of registrant’s name into English)
31, rue Henri Rochefort, 75017 Paris, France
(Address of principle executive offices)
BSN Financing Co. S.A.
(Translation of registrant’s name into English)
31, rue Henri Rochefort, 75017 Paris, France
(Address of principle executive offices)
[Indicate by check mark whether the registrant files annual reports under cover Form 20-F or Form 40-F.]
Form 20-F N/A | Form 40-F N/A |
[Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.]
Yes o No ý
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BSN Financing Co. S.A. |
| | |
| | |
Date: February 18, 2004 | By: | /s/ Pierre Laplanche | |
| Name: Pierre Laplanche on behalf of BSN Glasspack S.A. |
| Title: Director |
| | |
| | |
| BSN Glasspack S.A. |
| | |
| | |
Date: February 18, 2004 | By: | /s/ Jean-Jacques Lonjaret | |
| Name: Jean-Jacques Lonjaret |
| Title: Officer |
2

BSN GLASSPACK
Year 2003 Preliminary unaudited IFRS consolidated financial statements
BSN Glasspack, SA and Subsidiaries
In Mio Euros
Consolidated Statements of Operations
For the year ended December 31st, 2003
Income / (expense)
Net Sales | | 1,270.5 | |
| | | |
Gross Profit | | 220.7 | |
| | | |
Operating income | | 145.0 | |
| | | |
Financial expense, net | | (70.6 | ) |
| | | |
Income tax (expense)/benefit | | (11.9 | ) |
| | | |
Minority interest | | (0.2 | ) |
| | | |
Net Income | | 62.3 | |
| | | |
Recurring EBITDA | | 200.6 | |
| | | |
Recurring EBIT | | 116.8 | |
Consolidated Statements of Cash Flows
For the year ended December 31st, 2003
Provided / (used)
Cash flows provided by operating activities (a) | | 103.2 | |
| | | |
Cash flows used in investing activities (b) | | (30.3 | ) |
including acquisition of fixed assets | | (88.0 | ) |
| | | |
Debt decrease, net (a)+(b) | | | |
including isuance of debt, repayment on debt, dividends paid and increase/decrease in cash and cash equivalents | | 72.9 | |
Consolidated Balance Sheets
As of December 31, 2003
Cash and cash equivalents | | 52.6 | |
Trade accounts and notes receivables, net | | 223.9 | |
Inventories, net | | 289.1 | |
Other current assets and Short-term loans | | 44.3 | |
Property, plant and equipment, net | | 516.2 | |
Other non-current assets including intangible assets net, long-term receivables, available for sale non current investments, other assets; excluding goodwill | | 25.3 | |
Goodwill | | 1.3 | |
| | | |
Total assets | | 1,152.7 | |
| | | |
Senior Revolving credit facility | | 38.3 | |
Securitization | | 167.9 | |
Senior Capex facility | | 61.8 | |
Senior B | | 89.5 | |
Senior C | | 30.0 | |
Senior subordinated Notes 9.25% (second secured) | | 158.1 | |
Senior subordinated Notes 10.25% | | 143.4 | |
Loans from related parties (Shareholder loan) | | 18.6 | |
Other debt | | 7.9 | |
Total Short-term debt and Long-term debt | | 715.5 | |
Trade accounts and notes payable | | 201.4 | |
Provisions for retirement indemnities and pension obligations | | 113.0 | |
Provisions for risks and charges | | 1.6 | |
Deferred tax liabilities | | 34.8 | |
Other short-term and long-term liabilities | | 166.9 | |
Minority interest | | 0.2 | |
Net Equity | | (80.7 | ) |
| | | |
Total liabilities and net equity | | 1,152.7 | |
3